Organon (NYSE: OGN), a global healthcare company with a focus on womens health, will release its first quarter 2024 financial results on May 2, 2024, prior to the companys webcast and conference call...
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) announced that the phase 3 comparative clinical trial for the investigational Prolia and Xgeva (denosumab) biosimilar HLX14 met the...
Lauren Clason | (TNS) CQ-Roll Call
A recent tweak to a Medicaid formula could be behind the shake-up to inhaler products, a series of changes that have both benefited and harmed patients with asthma...
Shareholders of Organon & Co (OGN) looking to boost their income beyond the stocks 6.1% annualized dividend yield can sell the October covered call at the 20 strike and collect the premium...
Essex Financial Services Inc. raised its position in Organon Co. (NYSE:OGN Free Report) by 8.1% in the third quarter, according to its most recent Form 13F filing with the Securities...
Connor Clark Lunn Investment Management Ltd. acquired a new position in Organon Co. (NYSE:OGN Free Report) during the 3rd quarter, according to the company in its most recent...
Texas Permanent School Fund Corp decreased its stake in shares of Organon Co. (NYSE:OGN Free Report) by 2.0% in the 3rd quarter, according to the company in its most recent filing with...
Organon Co. (NYSE:OGN Free Report) had its price target hoisted by The Goldman Sachs Group from $16.00 to $18.00 in a research report sent to investors on Tuesday, Benzinga reports. The...
On 2/23/24, Organon & Co (OGN), Chemed Corp (CHE), and Equitable Holdings Inc (EQH) will all trade ex-dividend for their respective upcoming dividends. Organon & Co will pay its quarterly dividend...